ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Manager/Senior Manager, Statistical Programming at Beam Therapeutics - ApplyBlast

Manager/Senior Manager, Statistical Programming

Beam Therapeutics

3 months ago

4.1 on Glassdoor

Cambridge, MA, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Beam Therapeutics seeks a Manager/Senior Manager of Statistical Programming to lead statistical programming functions for clinical studies and regulatory submissions. The role involves managing CROs, developing programming strategies, and overseeing the creation of analysis datasets using SAS and R. This position requires collaboration with cross-functional teams to ensure successful execution of clinical programs and NDA/BLA submissions.

Responsibilities

Develop and maintain statistical programming functions for therapeutic areas
Manage CROs to generate analysis datasets for clinical study reports
Review and validate SDTM and ADaM analysis datasets created by vendors
Build and mentor a team of programmers to support clinical trials
Develop SAS programming infrastructure to improve data deliverable quality

Skills

Qualifications

MS in Statistics or Mathematics10 years Pharmaceutical/Biotech programming experienceNDA or BLA submission experienceAdvanced SAS programming skillsKnowledge of ICH guidelines and GCP

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.